Nyxoah股价在FDA批准Genio睡眠呼吸暂停治疗系统后飙升

英为财情
Aug 11, 2025

Investing.com -- Nyxoah SA (BR:NYXH) (NASDAQ:NYXH)股价在其Genio系统获得FDA批准用于治疗中度至重度阻塞性睡眠呼吸暂停(OSA)后跳涨9.4%。 这家比利时医疗技术公司获得了其创新舌下神经刺激(HGNS)设备的营销批准,适用于呼吸暂停-低通气指数在15至65之间的患者。Genio系统具有双侧刺激功能,采用无导线设计,并且与全身1.5T和3T...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10